Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FGN3P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,916
Award facts
- Contract value 100% obligated
- $12,916.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,916.48 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by January 29, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this order from its corporate office location in the same city. The delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical through December 2031.
This delivery order represents a routine pharmaceutical supply transaction within the broader context of DLA's medical supply chain operations supporting military healthcare programs. Cencora, Inc. and its subsidiary Amerisourcebergen Drug Corp have demonstrated consistent capability in fulfilling federal pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The company's primary contract vehicle with DLA Troop Support Medical enables efficient delivery of essential pharmaceutical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. This particular order for Descovy, an antiretroviral medication, reflects the company's role in supporting Department of Defense healthcare needs through competitive federal procurement channels.
Quick answers
Who was awarded contract SPE2DR26FGN3P?
SPE2DR26FGN3P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FGN3P worth?
The government has obligated $12,916 on SPE2DR26FGN3P.
Is contract SPE2DR26FGN3P an order under another contract?
Yes. SPE2DR26FGN3P is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGN3P competed?
The extent of competition for SPE2DR26FGN3P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award